Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy

Trial Profile

Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs Telapristone (Primary) ; Telapristone (Primary)
  • Indications Early breast cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 22 Jan 2018 Planned number of patients changed from 70 to 67.
    • 22 Jan 2018 Status changed from recruiting to active, no longer recruiting.
    • 09 Jan 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top